Total revenues in the second quarter were $39.8 billion, up 5.9% year over year.
Total net earnings in the second quarter were nearly $1.1 billion, up 8.6% since the same period last year.
The company reaffirmed its year-end adjusted EPS guidance to at least $6.80.
The company’s medical loss ratio was 87.6% in the second quarter and 87% during the same period last year. Days claims payable were 54 in the second quarter, compared to 52 a year ago.
As of June 30, Centene’s total membership stands at nearly 28.5 million. Medicaid membership has fallen to 13.1 million, decreasing 18.2% year over year. There are 4.4 million exchange members, 426,000 commercial group members, 1.1 million Medicare Advantage and supplement members, and 6.6 million Medicare prescription drug plans.
